Announced
Completed
Synopsis
Evonik Industries, a specialty chemicals company, completed the acquisition of PeroxyChem, a supplier of oxidative solutions, from One Equity Partners, a private equity firm for $640m. The purchase price including synergies is about 7.6 times the annual adjusted EBITDA. The acquisition will have a positive impact on Evonik's adjusted earnings per share and free cash flow already in 2020. “Despite the uncertainty, we posted a strong performance in 2019 and reported a further increase in sales and earnings in challenging economic conditions. Combining the two businesses will enable our motivated staff to develop even better solutions for our customers,” Bruce Lerner, PeroxyChem CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.